Nasdaq IPOs

Sustainable Opportunities Acquisition, a blank check company targeting a environmentally sustainable industrial business, filed on Tuesday with the SEC to raise up to $300 million in an initial public offering. The Dallas, TX-based company plans to raise $300 million by offering

Sustainable Opportunities Acquisition, a blank check company targeting a environmentally sustainable industrial business, filed on Tuesday with the SEC to raise up to $300 million in an initial public offering. The Dallas, TX-based company plans to raise $300 million by offering

Sustainable Opportunities Acquisition, a blank check company targeting a environmentally sustainable industrial business, filed on Tuesday with the SEC to raise up to $300 million in an initial public offering. The Dallas, TX-based company plans to raise $300 million by offering

The Renaissance International IPO Index (Ticker: IPOXUS), the underlying index for the Renaissance International IPO ETF (Ticker: IPOS), will implement the following constituent changes at the market's close on Friday, March 20, 2019:Additions: Pharmaron Beijing Poly Propert

The Renaissance International IPO Index (Ticker: IPOXUS), the underlying index for the Renaissance International IPO ETF (Ticker: IPOS), will implement the following constituent changes at the market's close on Friday, March 20, 2019:Additions: Pharmaron Beijing Poly Propert

The Renaissance International IPO Index (Ticker: IPOXUS), the underlying index for the Renaissance International IPO ETF (Ticker: IPOS), will implement the following constituent changes at the market's close on Friday, March 20, 2019:Additions: Pharmaron Beijing Poly Pr

The Renaissance International IPO Index (Ticker: IPOXUS), the underlying index for the Renaissance International IPO ETF (Ticker: IPOS), will implement the following constituent changes at the market's close on Friday, March 20, 2019:Additions: Pharmaron Beijing Poly Pr

The Renaissance IPO Index (Ticker: IPOUSA), the underlying index for the Renaissance IPO ETF (Ticker: IPO), will implement the following constituent changes at the market’s close on Friday, March 20, 2019:Additions: OneConnect Financial Technology PPD Reynolds Con

The Renaissance IPO Index (Ticker: IPOUSA), the underlying index for the Renaissance IPO ETF (Ticker: IPO), will implement the following constituent changes at the market’s close on Friday, March 20, 2019:Additions: OneConnect Financial Technology PPD Reynolds Con

The Renaissance IPO Index (Ticker: IPOUSA), the underlying index for the Renaissance IPO ETF (Ticker: IPO), will implement the following constituent changes at the market’s close on Friday, March 20, 2019:Additions: OneConnect Financial Technology PPD

The Renaissance IPO Index (Ticker: IPOUSA), the underlying index for the Renaissance IPO ETF (Ticker: IPO), will implement the following constituent changes at the market’s close on Friday, March 20, 2019:Additions: OneConnect Financial Technology PPD

Keros Therapeutics, a Phase 1 biotech developing treatments for hematological and musculoskeletal disorders, filed on Monday with the SEC to raise up to $86 million in an initial public offering.  The Lexington, MA-based company was founded in 2015 and booked $10 million in

Keros Therapeutics, a Phase 1/2 biotech developing treatments for hematological and musculoskeletal disorders, filed on Monday with the SEC to raise up to $86 million in an initial public offering.  The Lexington, MA-based company was founded in 2015 and booked $10 million i

Keros Therapeutics, a Phase 1/2 biotech developing treatments for hematological and musculoskeletal disorders, filed on Monday with the SEC to raise up to $86 million in an initial public offering.  The Lexington, MA-based company was founded in 2015 and booked $10 million i

Keros Therapeutics, a Phase 1/2 biotech developing treatments for hematological and musculoskeletal disorders, filed on Monday with the SEC to raise up to $86 million in an initial public offering.  The Lexington, MA-based company was founded in 2015 and booked $10 mill

Keros Therapeutics, a Phase 1/2 biotech developing treatments for hematological and musculoskeletal disorders, filed on Monday with the SEC to raise up to $86 million in an initial public offering.  The Lexington, MA-based company was founded in 2015 and booked $10 mill

Following the IPO Index’s sharpest drop ever recorded, one cannabis SPAC is keeping the IPO market alive, expected to raise $150 million in the week ahead. Social Capital’s latest SPACs (IPOB.U, IPOC.U) are also eligible to price this week. Led by former Canopy Growth

Following the IPO Index’s sharpest drop ever recorded, one cannabis SPAC is keeping the IPO market alive, expected to raise $150 million in the week ahead. Social Capital’s latest SPACs (IPOB.U, IPOC.U) are also eligible to price this week. Led by former Canopy Growth

Following the IPO Index’s sharpest drop ever recorded, one cannabis SPAC is keeping the IPO market alive, expected to raise $150 million in the week ahead. Social Capital’s latest SPACs (IPOB.U, IPOC.U) are also eligible to price this week. Led by former Cano

Following the IPO Index’s sharpest drop ever recorded, one cannabis SPAC is keeping the IPO market alive, expected to raise $150 million in the week ahead. Social Capital’s latest SPACs (IPOB.U, IPOC.U) are also eligible to price this week. Led by former Cano